Jason Cham

504 total citations
20 papers, 355 citations indexed

About

Jason Cham is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jason Cham has authored 20 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jason Cham's work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (7 papers) and Immunotherapy and Immune Responses (5 papers). Jason Cham is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (7 papers) and Immunotherapy and Immune Responses (5 papers). Jason Cham collaborates with scholars based in United States and Puerto Rico. Jason Cham's co-authors include Li Zhang, Lawrence Fong, David Y. Oh, Serena S. Kwek, Malek Faham, Mark Klinger, Munveer S. Bhangoo, Nadeem A. Sheikh, James Trager and Simon Letarte and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jason Cham

19 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Cham United States 8 272 173 84 61 32 20 355
Serena Zanotta Italy 13 203 0.7× 197 1.1× 97 1.2× 86 1.4× 35 1.1× 22 393
Vanesa de Luque Spain 3 255 0.9× 158 0.9× 38 0.5× 69 1.1× 25 0.8× 3 336
Carlos Linn United States 6 198 0.7× 96 0.6× 87 1.0× 34 0.6× 22 0.7× 15 283
Shengnan Luo China 9 178 0.7× 143 0.8× 74 0.9× 138 2.3× 76 2.4× 18 370
Kieran Adam United States 11 195 0.7× 191 1.1× 37 0.4× 73 1.2× 21 0.7× 26 350
Lisa Boselli France 10 281 1.0× 154 0.9× 83 1.0× 72 1.2× 32 1.0× 13 383
Adam Diehl United States 7 221 0.8× 54 0.3× 69 0.8× 54 0.9× 44 1.4× 16 299
Yan-Ping Mao China 2 364 1.3× 94 0.5× 125 1.5× 34 0.6× 18 0.6× 2 417
Wolfgang Moersig Germany 7 336 1.2× 251 1.5× 87 1.0× 60 1.0× 17 0.5× 12 432
Hannah L. Williams United Kingdom 5 287 1.1× 159 0.9× 94 1.1× 105 1.7× 106 3.3× 10 440

Countries citing papers authored by Jason Cham

Since Specialization
Citations

This map shows the geographic impact of Jason Cham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Cham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Cham more than expected).

Fields of papers citing papers by Jason Cham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Cham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Cham. The network helps show where Jason Cham may publish in the future.

Co-authorship network of co-authors of Jason Cham

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Cham. A scholar is included among the top collaborators of Jason Cham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Cham. Jason Cham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
New, Jacob, Jason Cham, Sunil M. Kurian, et al.. (2024). Effects of antineoplastic and immunomodulating agents on postvaccination SARS-CoV-2 breakthrough infections, antibody response, and serological cytokine profile. Journal for ImmunoTherapy of Cancer. 12(1). e008233–e008233. 3 indexed citations
2.
Cham, Jason, et al.. (2023). A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer. Frontiers in Oncology. 13. 1150777–1150777. 2 indexed citations
3.
Cham, Jason, et al.. (2023). Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?. Cancer Medicine. 12(9). 10243–10253. 4 indexed citations
4.
Yang, Hai, et al.. (2023). NAIR: Network Analysis of Immune Repertoire. Frontiers in Immunology. 14. 2 indexed citations
5.
He, Tao, et al.. (2022). Novel Ensemble Feature Selection Approach and Application in Repertoire Sequencing Data. Frontiers in Genetics. 13. 821832–821832. 1 indexed citations
6.
Cham, Jason, et al.. (2022). 6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers. PLoS ONE. 17(4). e0266781–e0266781. 4 indexed citations
7.
Cham, Jason, et al.. (2022). An observational study of hospitalized COVID-19 patients with cancer in San Diego county. Future Oncology. 18(6). 719–725. 3 indexed citations
8.
Cham, Jason, et al.. (2022). Hospitalization Requiring Intensive Care Unit Due to SARS-CoV-2 Infection Correlated With IgM Depression and IgG Elevation. Future Science OA. 8(3). FSO783–FSO783. 1 indexed citations
9.
Cham, Jason, et al.. (2021). Targeting the PI3K-AKT-mTOR Pathway in Castration Resistant Prostate Cancer: A Review Article. Clinical Genitourinary Cancer. 19(6). 563.e1–563.e7. 32 indexed citations
10.
Cham, Jason, et al.. (2021). Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report. Journal of Medical Case Reports. 15(1). 278–278. 14 indexed citations
11.
Cham, Jason, et al.. (2021). Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review. Frontiers in Oncology. 11. 763992–763992. 4 indexed citations
12.
Zhang, Li, Jason Cham, Tao He, et al.. (2021). Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy. Journal of Immunological Methods. 494. 113041–113041. 11 indexed citations
13.
Cham, Jason, et al.. (2021). Evaluating survival in patients with pancreatic adenocarcinoma and lung metastasis.. Journal of Clinical Oncology. 39(15_suppl). e16237–e16237.
14.
Zhang, Li, Hai Yang, Jason Cham, et al.. (2020). Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T. Cancer Immunology Research. 8(12). 1496–1507. 17 indexed citations
15.
Cham, Jason, Li Zhang, Serena S. Kwek, et al.. (2020). Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies. Journal for ImmunoTherapy of Cancer. 8(1). e000368–e000368. 7 indexed citations
16.
Zhang, Li, Jason Cham, Alan Paciorek, et al.. (2017). 3D: diversity, dynamics, differential testing – a proposed pipeline for analysis of next-generation sequencing T cell repertoire data. BMC Bioinformatics. 18(1). 129–129. 22 indexed citations
17.
Sheikh, Nadeem A., Jason Cham, Li Zhang, et al.. (2016). Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects. Cancer Research. 76(13). 3711–3718. 50 indexed citations
18.
Oh, David Y., Jason Cham, Li Zhang, et al.. (2016). Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire. Cancer Research. 77(6). 1322–1330. 173 indexed citations
19.
Oh, David Y., Jason Cham, Li Zhang, et al.. (2016). Association between T cell repertoire diversification and both clinical response as well as toxicity following immune checkpoint blockade in metastatic cancer patients.. Journal of Clinical Oncology. 34(15_suppl). 3029–3029. 3 indexed citations
20.
Fong, Lawrence, Jason Cham, Li Zhang, et al.. (2015). Changes in circulating and intratumoral T cell clonotypes in sipuleucel-T-treated prostate cancer patients.. Journal of Clinical Oncology. 33(15_suppl). e16008–e16008. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026